---
layout: post
title: "Over-the-Counter Monograph Drug User Fee Program-Facility Fee Rates for Fiscal Year 2024"
date: 2026-02-05 19:08:53 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2024-06723
original_published: 2024-03-29 00:00:00 +0000
significance: 8.00
---

# Over-the-Counter Monograph Drug User Fee Program-Facility Fee Rates for Fiscal Year 2024

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** March 29, 2024 00:00 UTC
**Document Number:** 2024-06723

## Summary

The Food and Drug Administration (FDA or the Agency) is announcing the over-the-counter (OTC) monograph drug facility (MDF) fee rates under the OTC monograph drug user fee program (OMUFA) for fiscal year (FY) 2024. The Federal Food, Drug, and Cosmetic Act (FD&C Act) authorizes FDA to assess and collect user fees from qualifying manufacturers of OTC monograph drugs and submitters of OTC monograph order requests (OMORs). This notice publishes the OMUFA facility fee rates for FY 2024.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2024/03/29/2024-06723/over-the-counter-monograph-drug-user-fee-program-facility-fee-rates-for-fiscal-year-2024)
- API: https://www.federalregister.gov/api/v1/documents/2024-06723

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
